BIRC6 and adrenal cortex carcinoma: Another important finding in the present study was the significantly higher percentage and intensity of BIRC6 expression in malignant types (ACC and MEC), compared with the benign type (PA), while the frequency of BIRC6 overexpression was not associated with patients’ sex or age, tumor size, and metastasis status.